Santa Farma Executive and Leadership Team

Sami Kiresepi, the Chief Executive Officer at Santa Farma, directs the company's overall strategy and operational execution. Kiresepi guides Santa Farma's prominent position in the Turkish healthcare sector, ensuring adherence to modern manufacturing techniques and fostering multinational collaborations. Overseeing the company's commitment to values such as sensitivity to people, openness to development, rational strength, and respect for work, workplace, and society, Kiresepi ensures these principles permeate all business functions. The Chief Executive Officer's leadership focuses on maintaining the strong reputation and trust Santa Farma has built since 1944. This role involves aligning all departments towards the company's mission of providing high-quality medications and services primarily to healthcare professionals. Sami Kiresepi drives the long-term vision for Santa Farma, emphasizing continuous improvement and market leadership within the pharmaceutical industry.

Esra Atış, the Director, Finance & Chief Financial Officer at Santa Farma, manages the company's financial health and strategic fiscal planning. Atış oversees all financial operations, including budgeting, forecasting, and financial reporting, ensuring Santa Farma's stability and growth. This executive guides investment strategies, optimizing resource allocation to support modern manufacturing techniques and multinational collaborations. Esra Atış ensures compliance with financial regulations and drives efficiency across all departments, reinforcing the company's rational strength. The Chief Financial Officer's role is critical in maintaining the trust Santa Farma has built by upholding financial transparency and accountability. By managing financial risks and identifying opportunities, Atış directly contributes to the company's ability to provide a wide range of medications and services. Esra Atış's financial acumen supports Santa Farma's long-term objectives and its commitment to societal well-being.

Derya Arslan, the Business Development Manager & Chief Marketing Officer, Alliance Management) at Santa Farma, spearheads strategic growth initiatives and cultivates key partnerships. Arslan identifies and develops new business opportunities, leveraging Santa Farma's established reputation and modern manufacturing capabilities. This executive manages alliance relationships, ensuring mutually beneficial collaborations that expand market reach and product offerings. Overseeing marketing strategies, Arslan ensures the company's wide range of medications effectively reaches healthcare professionals. The role involves analyzing market trends and competitor activities to inform business development plans. Derya Arslan plays a crucial part in translating Santa Farma's commitment to openness to development into tangible business expansion. This leadership position requires a deep understanding of the pharmaceutical landscape and a proactive approach to fostering innovation and securing long-term partnerships for Santa Farma.

Tugce Bespinar, the Chief Marketing Officer, Contract Manufacturing Operations Transfer & Quality Assurance Specialist at Santa Farma, drives market penetration and ensures operational excellence in manufacturing transfers. Bespinar develops and executes marketing campaigns that highlight Santa Farma's extensive product portfolio and commitment to quality. This dual-focused role also encompasses managing the transfer of contract manufacturing operations, ensuring seamless integration and adherence to stringent quality standards. Bespinar's expertise in quality assurance guarantees that all products meet regulatory requirements and customer expectations. Overseeing the communication of Santa Farma's values, including respect for work and society, Bespinar reinforces the company's trusted image. Tugce Bespinar's leadership ensures that Santa Farma's advanced manufacturing techniques are effectively marketed and that operational transfers maintain the highest levels of integrity and efficiency, supporting the company's growth and reputation.